Literature DB >> 24397925

Impact of vagal nerve stimulation on left atrial structure and function in a canine high-rate pacing model.

Kenya Kusunose1, Youhua Zhang, Todor N Mazgalev, David R Van Wagoner, James D Thomas, Zoran B Popović.   

Abstract

BACKGROUND: Cervical vagal nerve stimulation (VNS) can improve left ventricular dysfunction in the setting of heart failure (HF). However, little is known about the impact of VNS on left atrial (LA) function. The aim of this study was to compare LA mechanics and histology between control and VNS-treated animals during HF development. METHODS AND
RESULTS: Fifteen mongrel dogs were randomized into control (n=7) and VNS (n=8) groups. All dogs underwent 8 weeks of high-rate ventricular pacing (at 220 beats per minute for the first 4 weeks to develop HF and another 4 weeks at 180 beats per minute to maintain HF). LA contractile function (LA negative peak strain), conduit function (LA positive peak strain), and reservoir function (LA total strain) were measured from speckle tracking in 2 groups. At the end of the terminal study, the LA appendage was obtained. Baseline LA strains were comparable in the control and VNS-treated dogs. At 4 and 8 weeks of ventricular pacing, all LA strains were decreased and LA volumes were increased in the control group compared with the VNS group (P<0.05). Histological evaluation of the left atrium revealed that percent fibrosis was significantly lower in the VNS versus the control group (8±1% versus 13±1%; P<0.001). Finally, transmitral flow showed decreased atrial contribution to left ventricular filling in the control group (P<0.05).
CONCLUSIONS: VNS improved LA function and volumes and suppressed LA fibrosis in the canine high-rate ventricular pacing model. VNS is a novel and potentially useful therapy for improving LA function during HF.

Entities:  

Keywords:  atrial function, left; vagus nerve stimulation

Mesh:

Year:  2014        PMID: 24397925      PMCID: PMC4056587          DOI: 10.1161/CIRCHEARTFAILURE.113.000937

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  26 in total

1.  Atrial function during volume loading.

Authors:  R M Payne; H L Stone; E J Engelken
Journal:  J Appl Physiol       Date:  1971-09       Impact factor: 3.531

2.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

3.  Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example.

Authors:  M Eliasziw; S L Young; M G Woodbury; K Fryday-Field
Journal:  Phys Ther       Date:  1994-08

4.  Effects of vagal blockade on neurohumoral systems in conscious dogs with heart failure.

Authors:  D Elsner; E P Kromer; G A Riegger
Journal:  J Cardiovasc Pharmacol       Date:  1990-04       Impact factor: 3.105

5.  Determinants of forward pulmonary vein flow: an open pericardium pig model.

Authors:  P Barbier; S Solomon; N B Schiller; S A Glantz
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

6.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

7.  Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.

Authors:  Nessrine Hanna; Sophie Cardin; Tack-Ki Leung; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2004-08-01       Impact factor: 10.787

8.  Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats.

Authors:  Meihua Li; Can Zheng; Takayuki Sato; Toru Kawada; Masaru Sugimachi; Kenji Sunagawa
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

9.  Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse.

Authors:  Matteo Cameli; Matteo Lisi; Francesca Maria Righini; Alberto Massoni; Benedetta Maria Natali; Marta Focardi; Damiana Tacchini; Alessia Geyer; Valeria Curci; Cristina Di Tommaso; Gianfranco Lisi; Massimo Maccherini; Mario Chiavarelli; Massimo Massetti; Piero Tanganelli; Sergio Mondillo
Journal:  Am J Cardiol       Date:  2012-12-01       Impact factor: 2.778

10.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Authors:  A Hjalmarson; S Goldstein; B Fagerberg; H Wedel; F Waagstein; J Kjekshus; J Wikstrand; D El Allaf; J Vítovec; J Aldershvile; M Halinen; R Dietz; K L Neuhaus; A Jánosi; G Thorgeirsson; P H Dunselman; L Gullestad; J Kuch; J Herlitz; P Rickenbacher; S Ball; S Gottlieb; P Deedwania
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

View more
  6 in total

Review 1.  Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.

Authors:  Peng-Sheng Chen; Lan S Chen; Michael C Fishbein; Shien-Fong Lin; Stanley Nattel
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

2.  An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation.

Authors:  Kazuko Tajiri; Jean-Baptiste Guichard; Xiaoyan Qi; Feng Xiong; Patrice Naud; Jean-Claude Tardif; Antoine Da Costa; Kazutaka Aonuma; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

Review 3.  Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases.

Authors:  Xi He; Ming Zhao; Xueyuan Bi; Lei Sun; Xiaojiang Yu; Mei Zhao; Weijin Zang
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

4.  Targeting Sleep Disordered Breathing to Prevent Heart Failure: What is the Evidence?

Authors:  Kenya Kusunose; Reena Mehra
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-10-01

5.  Left Atrial Size and Function in a Canine Model of Chronic Atrial Fibrillation and Heart Failure.

Authors:  Adam Goldberg; Kenya Kusunose; Salima Qamruddin; L Leonardo Rodriguez; Todor N Mazgalev; Brian P Griffin; David R Van Wagoner; Youhua Zhang; Zoran B Popović
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

6.  Optogenetic Stimulation of Vagal Efferent Activity Preserves Left Ventricular Function in Experimental Heart Failure.

Authors:  Asif Machhada; Patrick S Hosford; Alex Dyson; Gareth L Ackland; Svetlana Mastitskaya; Alexander V Gourine
Journal:  JACC Basic Transl Sci       Date:  2020-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.